Private Equity

DayMark Wealth Partners and Opto Investments are rewriting the rules, using AI and aligned incentives to bring exclusive private market deals to affluent clients.

A new KKR-backed platform is betting big on turning game-day venues into year-round mega-districts, starting in Knoxville. It’s a multi-billion-dollar playbook.

With two strategic hires, Courser is betting on top-tier talent and financial discipline to scale its unique MSP network and dominate the complex SMB AI landscape.

Middlefield's new Discovery 2026 IPO offers a 100% tax deduction by investing in Canadian gold miners. But is this tax-savvy play worth the inherent risk?

While crypto exchanges tout record trading on SpaceX derivatives, a behind-the-scenes failure to secure actual shares reveals a deep rift with traditional finance.

A top wealth firm's western expansion reveals a deeper trend: the future of managing fortunes lies in combining national resources with deep local roots.

John Bratsakis, a 35-year veteran known for co-founding the innovative Plexcity cooperative, will take the helm of The League of Credit Unions & Affiliates.

Private equity firm Oakline acquires a major affordable housing manager. Is this the future of community management or a simple play for scale?

Ezurio’s new CFO, a veteran of $625M+ in acquisitions, isn’t just a financial hire; he’s a signal of an aggressive growth plan for the critical IoT market.

Beyond a simple merger, Conrex Group's acquisition of Formweld Fitting signals a strategic shift toward creating a resilient, one-stop industrial giant.

A Michigan ear clinic's new partnership reveals a seismic shift in healthcare. Private equity and MSOs promise growth, but what does this mean for doctors?

REPAY's acquisition of KUBRA, fueled by a massive $500M loan from Silver Point, creates a bill payment giant and signals private credit's growing M&A muscle.

With a $300M+ war chest, Adam Goodman's 'tradigital' studio aims to merge YouTube virality with Hollywood's franchise-building machine.

Flexstone Partners' acquisition of Glouston creates a $15B giant, signaling a strategic shift in private equity and a major win for parent company Natixis.

Laprophan's acquisition of Rivopharm is more than a deal; it's a strategic blueprint for emerging market players aiming for the global pharmaceutical stage.

As tech IPOs stall, a new breed of private credit fund offers a lifeline to employees with 'paper wealth,' unlocking billions in value from top unicorns.

A BofA study reveals a seismic shift in wealth, where longer lives and a generational split over crypto are creating unprecedented financial complexity.

Medincell's latest results show a planned loss but reveal a strategic shift to recurring royalties, fueled by UZEDY®'s success and a pipeline set for growth.

In a tough fundraising climate where capital is scarce, Align Capital Partners just raised over $1.1B. Here's how their disciplined strategy is winning.

A major merger backed by private equity signals a new era for pharmaceutical training, blending AI, behavioral science, and launch expertise to tackle industry complexity.